Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 4 (2007), Issue 10 (October)

1. Usefulness of human leucocyte antigen-B27 subtypes in predicting ankylosing spondylitis: Taiwan experience.
   Intern Med J, 37(11): 749-52. [Abstract] [Full-text]
2. A child with primary Sjögren syndrome and a review of the literature.
   Clin Pediatr (Phila), 46(8): 738-42. [Abstract] [Full-text]
3. Rheumatoid arthritis: the role of reactive oxygen species in disease development and therapeutic strategies.
   Antioxid Redox Signal, 9(10): 1541-67. [Abstract] [Full-text]
4. The anti-inflammatory effect of A3 adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis.
   Expert Opin Investig Drugs, 16(10): 1601-13. [Abstract] [Full-text]
5. Parotid gland involvement, the presenting sign of high grade non-Hodgkin lymphoma in two patients with Gaucher disease and sicca syndrome.
   J Inherit Metab Dis, 30(5): 825. [Abstract] [Full-text]
6. Optimal use of methotrexate: the advantages of tight control.
   Ann Rheum Dis, 66(11): 1409-10. [Abstract] [Full-text]
7. Does extremity-MRI improve erosion detection in severely damaged joints? A study of long-standing rheumatoid arthritis using three imaging modalities.
   Ann Rheum Dis, 66(11): 1538-40. [Abstract] [Full-text]
8. Limited correlation between the Health Assessment Questionnaire (HAQ) and EuroQol in rheumatoid arthritis: questionable validity of deriving quality adjusted life years from HAQ.
   Ann Rheum Dis, 66(11): 1534-7. [Abstract] [Full-text]
9. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial).
   Ann Rheum Dis, 66(11): 1443-9. [Abstract] [Full-text]
10. Low-dose glucocorticoid therapy decreases risk for treatment-limiting infusion reaction to infliximab in patients with rheumatoid arthritis.
    Ann Rheum Dis, 66(11): 1462-6. [Abstract] [Full-text]
11. Opposing effects of the D70 mutation and the shared epitope in HLA-DR4 on disease activity and certain disease phenotypes in rheumatoid arthritis.
    Ann Rheum Dis, 66(11): 1497-502. [Abstract] [Full-text]
12. Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment.
    Ann Rheum Dis, 66(11): 1518-24. [Abstract] [Full-text]
13. Hand bone densitometry: a more sensitive standard for the assessment of early bone damage in rheumatoid arthritis.
    Ann Rheum Dis, 66(11): 1513-7. [Abstract] [Full-text]
14. Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.
    Ann Rheum Dis, 66(11): 1503-7. [Abstract] [Full-text]
15. Changes in priorities for improvement in patients with rheumatoid arthritis during 1 year of anti-tumour necrosis factor treatment.
    Ann Rheum Dis, 66(11): 1485-90. [Abstract] [Full-text]
16. A novel gene variation of TNFalpha associated with ankylosing spondylitis: a reconfirmed study.
    Ann Rheum Dis, 66(11): 1419-22. [Abstract] [Full-text]
17. Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis.
    Ann Rheum Dis, 66(11): 1450-5. [Abstract] [Full-text]
18. Macrophage migration inhibitory factor polymorphisms do not predict therapeutic response to glucocorticoids or to tumour necrosis factor alpha-neutralising treatments in rheumatoid arthritis.
    Ann Rheum Dis, 66(11): 1525-30. [Abstract] [Full-text]
19. Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis.
    Ann Rheum Dis, 66(11): 1508-12. [Abstract] [Full-text]
20. The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice.
    Ann Rheum Dis, 66(11): 1473-8. [Abstract] [Full-text]
21. QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries.
    Ann Rheum Dis, 66(11): 1491-6. [Abstract] [Full-text]
22. Reversal of multifocal cutaneous lymphoproliferative disease associated with Epstein-Barr virus after withdrawal of methotrexate therapy for rheumatoid arthritis.
    J Am Acad Dermatol, 57(5): S69-71. [Abstract] [Full-text]
23. Neutrophilic panniculitis in infancy: a cutaneous manifestation of juvenile rheumatoid arthritis.
    J Am Acad Dermatol, 57(5): S65-8. [Abstract] [Full-text]
24. Cellular targets of interleukin-18 in rheumatoid arthritis.
    Ann Rheum Dis, 66(11): 1411-8. [Abstract] [Full-text]
25. Late consequences of chronic pediatric illness.
    Psychiatr Clin North Am, 30(4): 819-35. [Abstract] [Full-text]
26. Primary lymphoma of the subglottic airway in a patient with Sjogren's syndrome mimicking high laryngotracheal stenosis.
    Ann Thorac Surg, 84(5): 1756-8. [Abstract] [Full-text]
27. Changes in bone mineral density in premenopausal women with rheumatoid arthritis during a two-year follow-up.
    Joint Bone Spine, 74(5): 482-7. [Abstract] [Full-text]
28. The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients.
    Joint Bone Spine, 74(5): 440-5. [Abstract] [Full-text]
29. Efficacy of thalidomide in systemic onset juvenile rheumatoid arthritis.
    Joint Bone Spine, 74(5): 500-3. [Abstract] [Full-text]
30. Pathophysiological links between rheumatoid arthritis and the Epstein-Barr virus: an update.
    Joint Bone Spine, 74(5): 418-26. [Abstract] [Full-text]

© 2004-2010 Rheumatoid Arthritis Research Today. All Rights Reserved.